Noven Pharmaceuticals Inc. is voluntarily recalling approximately 294,020 boxes of Combipatch (estradiol/norethindrone acetate transdermal system), a prescription hormone replacement therapy patch. The recall was initiated because the products failed stability specifications specifically related to 'shear' testing, which measures the adhesive's ability to remain stable and functional over time. This defect can lead to issues with how the patch adheres or how the medication is delivered through the skin.
A failure in shear stability specifications means the adhesive patch may not perform as intended during its shelf life, potentially affecting the consistent delivery of the medication or the patch's ability to stay attached to the skin. While no specific injuries have been reported in this data, failed stability can lead to ineffective treatment of the symptoms the medication is intended to manage.
Contact healthcare provider and return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.